Recent Quotes (30 days)

You have no recent quotes
chg | %

Avatex Corporation  

(Public, OTCMKTS:AVATQ)   Watch this stock  
Find more results for PINK:AVATQ
0.0001
0.0000 (0.00%)
Oct 4 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.00
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 1,964.00
P/E     -
Div/yield     -
EPS -0.39
Shares 19.64M
Beta     -
Inst. own 0%

Key stats and ratios

Q3 (Sep '02) 2002
Net profit margin -809.54% -
Operating margin -515.77% -
EBITD margin - -
Return on average assets -49.99% -11.03%
Return on average equity - -231.04%
Employees 21 -
Carbon Disclosure Rating - -

Address

Suite 310, 17000 Preston Road
DALLAS, TX 75248
United States - Map
+1-972-8183938 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Avatex Corporation is a holding company that, along with its subsidiaries, owns interests in other corporations and partnerships. The Company consolidated Chemlink Laboratories, LLC (Chemlink) at March 31, 2002 as a result of its control of 50% of the voting interests of Chemlink through its 59% interest in Chemlink Acquisition Company, LLC. Chemlink is primarily engaged in the development, manufacture and distribution of effervescent tablet and granule formulations for consumers and businesses for use in cleaning, disinfecting and sterilization applications. The Company also owns 48% of Phar-Mor, Inc., which operates a chain of discount retail drugstores. Phar-Mor filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code on September 24, 2001. In December 2002, the Company and five subsidiaries filed a voluntary petition for protection under Chapter 11 of the United States Bankruptcy Code.

Officers and directors

Robert H. Stone Chief Restructuring Officer, Vice President, General Counsel, Secretary, Director
Age: 42